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http://dx.doi.org/10.1016/j.jfma.201Background/Purpose: Mesh-augmented vaginal surgery for treatment of pelvic organ prolapse
(POP) does not meet patients’ needs. This study aims to test the hypothesis that fascia tissue
engineering using adipose-derived stem cells (ADSCs) might be a potential therapeutic strategy
for reconstructing the pelvic floor.
Methods: Human ADSCs were isolated, differentiated, and characterized in vitro. Both ADSCs
and fibroblastic-differentiated ADSCs were used to fabricate tissue-engineered fascia equiva-
lents, which were then transplanted under the back skin of experimental nude mice.
Results: ADSCs prepared in our laboratory were characterized as a group of mesenchymal stem
cells. In vitro fibroblastic differentiation of ADSCs showed significantly increased gene expression
of cellular collagen type I and elastin (p < 0.05) concomitantly with morphological changes. By
contrast, ADSCs cultured in control medium did not demonstrate these changes. Both of the en-
grafted fascia equivalents could be traced up to 12 weeks after transplantation in the subsequent
animal study. Furthermore, the histological outcomes differed with a thin (111.0  19.8 mm)
lamellar connective tissue or a thick (414.3 114.9 mm)adhesive fibrous tissue formation between
the transplantation of ADSCs and fibroblastic-differentiatedADSCs, respectively. Nonetheless, the
implantation of a scaffold without cell seeding (the control group) resulted in a thin
(102.0 17.1 mm) fibrotic band and tissue contracture.have no conflicts of interest relevant to this article.
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Tissue-engineered fascia from adipose-derived SCs 705Conclusion: Our results suggest the ADSC-seeded implant is better than the implant alone in
enhancing tissue regeneration after transplantation. ADSCswith orwithout fibroblastic differenti-
ation might have a potential but different role in fascia tissue engineering to repair POP in the
future.
Copyright ª 2013, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
The lifetime risk of undergoing surgery to repair pelvic organ
prolapse (POP) is 11e19% in the general female popula-
tion.1,2 However, attempts to correct this problem still result
in a high failure rate and a significant number of patients
need re-operation.3 In order to improve surgical outcomes,
the use of synthetic meshes for the reinforcement of POP
repair has become popular.4 Unfortunately, evidence of ef-
ficacy for these procedures is not convincing, and rates of
complications such as vaginal erosions, pain, infections, and
shrinkage are unacceptably high.5,6,7 Recently, stem cell-
based tissue engineering and cellular therapy, which are
underway in genitourinary tract reconstruction,8,9,10 have
been proposed for treatment of POP to avoid the compli-
cations associated with surgical meshes.11,12
During the past decade, different types of stem cells,
especially bone marrow-derived mesenchymal stem cells
(MSCs) and skeletal muscle-derived stem cells, have been
used in preclinical and clinical studies for treating stress
urinary incontinence.9,10 However, little effort has been
made on the treatment of POP using these cells. Ho et al
found that muscle-derived stem cells seeded into biological
grafts stimulated vaginal tissue repair in rats and suggested
that this might be a promising approach for vaginal repair.13
Previously, we successfully fabricated a fascia equivalent
in vitro and in vivo using human vaginal fibroblasts from
patients with POP.14 However, these options may not be
optimal for the eventual implementation in POP repair
because these stem and/or progenitor cells are difficult to
obtain in adequate quantity and quality.
By contrast, adipose-derived stem cells (ADSCs), which are
abundant and easy to obtain from discarded adipose tissue,
have been used in stem cell-based therapy across several
different medical disciplines.9,15 In addition, some studies
have shown that ADSCs have equal or superior therapeutic
potential compared to bone marrow-derived MSCs.16,17 In
order to explore the potential of using ADSCs as a cell source
for POP repair, we conducted this preclinical study. In this
study,we tried to (1) isolate, expand, andcharacterizehuman
ADSCs in vitro; (2) induce fibroblastic differentiation of ADSCs
in vitro; (3) useADSCs andfibroblastic-differentiatedADSCs to
fabricate tissue-engineered fascia equivalents in vitro and
evaluate the histological outcomes after in vivo trans-
plantation. A murine model for experiments of tissue regen-
eration was used in this study.14,18,19
Methods
Tissue biopsy and cell isolation
A piece of subcutaneous adipose tissue was excised from
the abdomen of women who had undergone gynecologicalsurgery after informed consent was given using an Institu-
tional Review Board (IRB)-approved protocol at our insti-
tution (TCVGH IRB No. S07125). ADSCs were isolated
following the methods described by Zuk et al.20
Cell culture, expansion, and senescence assay
Following cell plating, the ADSCs were maintained in a
humidified incubator at 37C/5% CO2 in control medium
(CM) consisting of Dulbecco’s modified Eagle medium
(DMEM; Gibco, Grand Island, NY) supplemented with 10%
fetal bovine serum (FBS; Gibco) and 1% penicillin/strepto-
mycin solution (Gibco) at a density of 5  106 nucleated
cells/10-cm tissue culture dish. The medium was changed
twice weekly thereafter. Cells were passaged with 0.25%
trypsin/0.1% EDTA upon reaching 80% confluence. The se-
nescent cultured cells were detected by the Senescence
beta-Galactosidase Staining Kit during cell expansion (Cell
Signaling Technology Inc., Beverly, MA, USA) according to
the manufacturer’s protocol.
Characterization of ADSCs in vitro
In vitro characterization was done according to the minimal
criteria set by The International Society for Cellular Ther-
apy in 2006 for defining multipotent MSCs.21 Additional cell
surface antigens were evaluated according to methods used
by Mitchell et al22 and Varma et al.23 ADSCs were confirmed
by the typical cell morphology, adherence to plastics,
specific cell surface antigen expression, and potential for
tri-lineage (i.e., adipogenic, chondrogenic, and osteo-
blastic) differentiation. Homogeneous populations of
cultured adherent cells at passages 3e5 were used in the
following experiments. Each experiment was repeated
three times.
Induction of fibroblastic differentiation of ADSCs
in vitro
Fibroblastic differentiation was performed according to the
protocol described by Lee et al.24 In brief, ADSCs were
treated with CM supplemented with 100 ng/mL of recom-
binant human connective tissue growth factor (rhCTGF;
PROSPEC Protein Specialists, East Brunswick, NJ) and
50 mg/mL ascorbic acid, and the medium was changed
twice a week. At the same time, cultured adherent cells
incubated in CM were used as a negative control. Following
fibroblastic differentiation, the mRNA of extracellular ma-
trix (ECM) molecules including collagen type I, collagen
type III, collagen type V, elastin, and tenascin-C were
assayed weekly by reverse transcription polymerase chain
reaction (RT-PCR) at baseline until week 4. Meanwhile, two
master transcription factors, peroxisome proliferator-
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related transcription factor 2 (RUNX2) for osteogenesis,
were evaluated, respectively. PCR amplification was per-
formed using the primer sequences established by Gen-
Bank. RT-PCR products were analyzed with conventional
agarose gel electrophoresis and ethidium bromide staining.
Densitometry with image analysis software (Bio1D; Vilber
Lourmat, Marne La Valle´e, France) was used to determine
and quantify the intensity of the bands.
Fabrication of tissue-engineered fascia equivalents
in vitro
The fascia equivalents were prepared according to previously
described methods.14 In brief, a prepared collagen solution
containing ADSCs or fibroblastic-differentiated ADSCs
(3.5 107 cells/mL in 2.15mLof1DMEMsupplementedwith
23.3% FBS in final collagen concentration of 1.1 mg/mL) was
applied to the biodegradable poly-DL-lactico-glycolic acid
(PLGA) mesh (Ethicon, Edinburgh, UK), 1 cm  1 cm in size.
The scaffolds seededwithADSCs orfibroblastic-differentiated
ADSCs (tissue-engineered fascia equivalents) were kept in a
submerged culture for 24 hours in standard culture conditions
before the animal study. The seeded cells were labeled in
advance with a dialkyl-carbocyanine fluorescent solution
(Vybrant DiI; Molecular Probes, Eugene, OR) according to the
manufacturer’s protocol. Cells were stained and tracked
in vitro and in vivo using the same dye.
Graft transplantation and tissue procurement
Animal studies were performed according to the guidelines
set by the Animal Research Committee at our institution.
Three sets (9 mice in each set) of experimental nude mice
were prepared for the transplantation. The tissue-
engineered fascia equivalents were transplanted under the
back skin of experimental female nude mice (8 weeks old)
(two sets). Meanwhile, PLGA mesh mixed with collagen gel
without cell seeding was used for implantation as the control
(1 set). At 4 weeks, 8 weeks, and 12 weeks after trans-
plantation, the animals were sacrificed and tissue samples
were harvested for subsequent histological analysis.
Histological analysis
All specimens were fixed with 4% paraformaldehyde and
embedded with paraffin (H&E, Masson’s trichrome staining)
or O.C.T. compound (Tissue-Tek; Sakura Finetek, Torrance,
CA, USA). Tissue sections were cut for histological exami-
nation. All slides were photographed, and images were
digitalized using a color digital camera and imaging soft-
ware (Spot, version 2.1; Diagnostic Instruments, Sterling
Heights, MI, USA). Localization of DiI-labeled cells was
determined using a fluorescent microscope (Axiovert 200M;
Carl Zeiss, Oberkochen, Germany) filtered for excitation/
emission at 546/590 nm.
Statistical analysis
All data were presented as mean  standard deviation (SD).
The statistical analysis was performed using one-wayanalysis of variance (ANOVA) repeated measurement for
multiple comparisons. The level of statistical significance
was set at p < 0.05.
Results
Tissue harvest and cell yield
The mass of adipose tissue harvested, number of isolated
nucleated cells and adherent cells, and yield of adherent
cells per gram of tissue sample from six women is summa-
rized in Table 1. The average mass of harvested tissue was
5.47  1.68 grams. The average yield of adherent cells was
0.83  0.22  105 per gram of harvested tissue.
Growth kinetics of ADSCs
To examine the long-term growth kinetics of ADSCs, we
measured cumulative population doublings with respect to
passage numbers (Fig. 1A). ADSCs underwent an average of
1.8 population doublings before the first passage. An
average of 2.0 population doublings was observed upon
subsequent passages. A linear relationship between cumu-
lative population doubling and passage number was
observed (P10Z 85  9.1 days in culture). Cell senescence
in cultures at passages 1, 5, and 9 are shown in Fig. 1B,C,
respectively. Cell cultures at passage 1 exhibited no
appreciable beta-galactosidase staining. A significant in-
crease in beta-galactosidase staining was noted in later
passages. The percentage of senescent cells remained
below 5% throughout the nine passages.
In vitro characterization of ADSCs
ADSCs expanded easily in vitro and exhibited a homoge-
neous cell population of the typical spindle-shaped cell
morphology with adherence to plastics after the third pas-
sage (Fig. 2A). As expected, ADSCs expressed the MSC-
associated antigens (i.e., CD29, CD44, CD73, CD90, CD105,
CD166) at varying degrees, but did not (orminimally) express
the hematopoietic stem cell-associated antigens (i.e., CD14,
CD19, CD34, CD45, CD117) or endothelial cell-associated
antigens (i.e., CD31, von Willebrand factor) or human
leukocyte antigen (HLA)-DR molecules (Fig. 2B). The tri-
lineage (i.e., adipogenic, chondrogenic, and osteoblastic)
differentiation potential of ADSCs was checked by cyto-
chemical staining with Oil Red-O, Alcian Blue, and Alizarin
Red S (Sigma-Aldrich Inc., St. Louis, MO). The mean number
of Oil Red-O (adipogenic), Alcian Blue (chondrogenic), and
Alizarin Red S (osteogenic)-positive staining cells measured
in six donors was 71.8  6.7%, 70.2  14.7%, and 58.2 9.9%
of the total ADSC number, respectively (Fig. 2C). By contrast,
undifferentiated ADSCs at the same passage number did not
show positive labeling for tri-lineage differentiation.
Fibroblastic differentiation of ADSCs
The differentiation induced a significant increase in the
gene expression of collagen type I and elastin in ADSCs by
both qualitative and quantitative analysis via RT-PCR
Table 1 Summary of the amount of adipose tissue harvested, total nucleated and adherent cells isolated, and cell yield from
six women who had undergone gynecological surgery.
Patient data Adipose tissue
No. Age Parity Menopause BMI
(kg/m2)
Mass of
harvested
tissue (g)
Total
nucleated
cells (106)
Number of
adherent
cells (105)
Yield
adherent
cells (105)/g
1 20 0 N 25.8 8.14 10.50 6.87 0.84
2 52 2 N 22.6 5.93 1.33 4.89 0.82
3 46 1 N 25.1 6.13 8.96 2.85 0.46
4 60 2 Y 24.0 4.53 10.50 4.35 0.96
5 53 3 N 30.1 4.90 1.61 5.52 1.13
6 49 1 N 26.0 3.20 8.00 2.53 0.79
Average 47 1.5 25.6 5.47 6.82 4.50 0.83
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of collagen type I and elastin content in ADSCs increased
significantly by approximately 2.0 and 1.8 fold, respec-
tively, in comparison with ADSCs at baseline (p < 0.05).
There were no statistically significant changes in the mRNA
expression of other ECM molecules including collagen type
III, collagen type V, and tenascin-C. However, the ratios of
collagen type I/III and collagen type I/IIIþV increased
progressively from baseline to 2.04 and 2.38 fold, respec-
tively, after 4 weeks of culture. Meanwhile, the gene
expression of PPAR-g was not induced and that of RUNX2
was stable (Supplementary Fig. 1). In addition to changes in
genetic expression, cell morphology changed progressively
from a slender shape to a plump shape with more cytoplasmFigure 1 (A) The growth kinetics by cumulative population doubl
of adipose-derived stem cells (ADSCs) (n Z 6). Arrow: senescent cand a more vesicular-like nucleus (Fig. 3C). By contrast, no
significant changes of genetic or morphological expression
were observed in the control group.Tissue-engineered fascia equivalents and
experimental animal model
Before transplantation, tissue-engineered fascia equiva-
lents were observed microscopically. The previously DiI-
labeled ADSCs or fibroblastic-differentiated ADSCs were
identified under fluorescence microscopy. Both the cell
density and distribution were similar between groups
(Fig. 4A,B). The histology of the normal back skin inings and (B,C) senescence assay by beta-galactosidase staining
ells (blue). *p < 0.05; **p < 0.01.
Figure 2 In vitro characterization of adipose-derived stem cells (ADSCs) (n Z 6). (A) Microscopic cell morphology. Original
magnification, 100. (B) Detection of cell surface antigen by flow cytometry. (C) Tri-lineage differentiation potential by cyto-
chemical staining with Oil Red-O (adipogenic), Alcian Blue (chondrogenic), and Alizarin Red S (osteogenic). Original magnification,
100. P Z passage.
Figure 3 (A,B) Detection and quantification of the mRNA of extracellular matrix molecules by reverse transcription polymerase
chain reaction (RT-PCR), with (C) concomitant monitoring of cell morphological changes during the in vitro fibroblastic differen-
tiation of adipose-derived stem cells (ADSCs) (n Z 6). *p < 0.05; **p < 0.01.
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tive tissue (283.8  44.5 mm) between the superficial and
deep muscle layers contributes to a plane where surgical
dissection can easily take place for mesh implantation
(Fig. 4CeF).
Outcomes of in vivo transplantation
The histological findings of the in vivo transplantation of
the two tissue-engineered fascia equivalents at 4 weeks
and 8 weeks indicated a common trend of mesh degrada-
tion, spindle-shaped cell proliferation with matrix deposi-
tion, and regression of inflammatory reactions with time.
However, the tissue formation from the transplantation of
fibroblastic-differentiated ADSCs seemed more fibrotic
than that from the transplantation of ADSCs.
At 12 weeks, the subcutaneous transplantation of the
tissue-engineered fascia equivalents in nude mice using
ADSCs or fibroblastic-differentiated ADSCs could be detec-
ted under fluorescence microscopy by the demonstration of
DiI-labeled cells (Figs. 5A and 6A). The collagen component
was abundant in the neo-tissue formation shown by Mas-
son’s Trichrome staining (Figs. 5B and 6B). Furthermore,
the neo-tissue formation by the transplantation of ADSCs
was a thin (111.0  19.8 mm) and well-organized lamellarstructure, which mimicked normal fascia (Fig. 5C,D). By
contrast, the neo-tissue formation by the transplantation of
fibroblastic-differentiated ADSCs appeared as a thick
(414.3  114.9 mm) and undulated, adhesive fibrous tissue,
which extended into the surrounding host tissue layers and
caused some focal inflammatory reactions (Fig. 6C,D).
The results of the control group of implantation of PLGA
mesh mixed with collagen gel without cell seeding were
presented in Fig. 7. There was a formation of a thin
(102.0  17.1 mm) band of fibrotic tissue and contracture of
host tissue at the implantation site. A comparison between
the histological outcomes of the normal back skin, the
controls, and the treated animals under high-powered
magnification is detailed in Fig. 8.
Discussion
In the present study, human ADSCs were prepared and
characterized as a group of MSCs. Culturing ADSCs in me-
dium that supports fibroblastic differentiation induced both
morphological and gene expression changes in these cells to
become functional fibroblast-like cells. Subsequently, we
used ADSCs and fibroblastic-differentiated ADSCs to fabri-
cate tissue-engineered fascia equivalents, which were then
transplanted subcutaneously in experimental nude mice.
Figure 4 Tissue-engineered fascia equivalents in vitro and an experimental animal model. After 24 hours of in vitro cultivation, a
fascia equivalent was made with biodegradable poly-DL-lactico-glycolic acid (PLGA) mesh and adipose-derived stem cells (ADSCs)
(A) or fibroblastic-differentiated ADSCs (B). A very loose connective tissue was noted between the superficial muscle (SM) and deep
muscle (DM) layers of the normal back skin in experimental nude mice (C, C1, C2: H&E staining) where mesh was implanted (D).
Original magnification, 40 (C,D), 100 (A,B,C1), 200 (C2); internal scale marker Z 100 mm. DM Z deep muscle; SK Z skin;
SM Z superficial muscle.
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Figure 5 The histological outcomes of the in vivo transplantation of the tissue-engineered fascia equivalent using adipose-
derived stem cells (ADSCs) after 12 weeks. (A) Under fluorescence microscopy, a thin neo-tissue formation full of the previously
DiI-labeled cells (red) is shown. (B) Masson’s Trichrome staining revealed collagen content (blue) within the neo-tissue formation
between the superficial muscle (SM) and deep muscle (DM) layers. (C,D) H&E staining revealed lamellar, loose connective tissue
formation between the SM and DM layers. In specimen (C), fine tissue infiltration into the DM layer (C1eC2) was noted. In specimen
(D), graft residual located within the newly formed loose connective tissue was noted (D1eD2). Original magnification, 50 (A,B),
40 (C,D), 100 (C1,D1), 200 (C2,D2); internal scale markerZ 100 mm. DMZ deep muscle; SKZ skin; SMZ superficial muscle.
Figure 6 The histological outcomes of the in vivo transplantation of the tissue-engineered fascia equivalent using fibroblastic-
differentiated adipose-derived stem cells (ADSCs) after 12 weeks. (A) Under fluorescence microscopy, a thick neo-tissue formation
full of the previously DiI-labeled cells (red) was noted. (B) Masson’s Trichrome staining revealed collagen content (blue) within the
neo-tissue formation between the superficial muscle (SM) and deep muscle (DM) layers. (C,D) H&E staining revealed undulated,
dense fibrous tissue formation that extends into the SM and DM layers (C1,D2). Focal inflammatory reactions with lymphocytic
infiltration (C2) or granulation tissue formation (D1) were noted. Original magnification, 50 (A,B), 40 (C,D), 100 (C1,D1), 200
(C2,D2); internal scale marker Z 100 mm. DM Z deep muscle; SK Z skin; SM Z superficial muscle.
Figure 7 The histological results of the in vivo implantation of the poly-DL-lactico-glycolic acid (PLGA) mesh mixed with collagen
gel without cell seeding after 12 weeks. (A) No fluorescence signal was detected under fluorescence microscopy. (B) Masson’s
Trichrome staining revealed collagen content (blue) within the neo-tissue formation between the superficial muscle (SM) and deep
muscle (DM) layers. (C,D) A thin band of fibroblast proliferation and dense matrix deposition was noted in the previous implantation
site (H&E staining). Within the band, a hypertrophic nerve fiber (C1: N) and areas of matrix nodules admixed with adipocytes (D1:
arrows) were seen. Original magnification, 50 (A,B), 40 (C,D), 100 (C1,D1), 200 (C2,D2); internal scale marker Z 100 mm.
DM Z deep muscle; N Z nerve; SK Z skin; SM Z superficial muscle.
712 M.-J. Hung et al.Both of the engrafted fascia equivalents could be traced up
to 12 weeks after transplantation and resulted in very
different histological outcomes, which is a novel finding.
Our results suggest that ADSCs could be a potential cell
source for tissue-engineered fascia equivalents for the
reconstruction of the pelvic floor.
The cell yield [0.8 (0.5e1.1)  105 cells/g] of isolated
ADSCs at our laboratory was lower than the results [2.0
(0.5e3.0)  105 cells/g] reported by De Ugarte et al16 who
used similar methodology. The discrepancy in the cell yield
may have been confounded by factors such as different
donors, sites, and procedures of tissue harvesting.25,26
Although there was a lower cell yield, ADSCs prepared in
our laboratory maintained a relatively constant prolifera-
tion rate as well as a low (<5%) level of senescence during
extended culture periods. These characteristics are
intrinsic properties of stem cells and are essential for im-
plications in cell-based therapies and tissue engineer-
ing.15,16,17,20 Currently, most preclinical and clinical studies
on stem cell-based treatment of stress urinary incontinence
using bone marrow-derived MSCs or muscle-derived stem
cells have shown impressive efficacy.9,10 However, we
suggest that ADSCs might be a better potential cell source
than these cells in pelvic floor reconstruction because a
large number of stem cells are needed. Human ADSCs have
the advantages of being easily harvested in large amounts,
cultured, and expanded in vitro.9,15,16,17,20Cultured ADSCs in this study were further characterized
in vitro according to the minimal criteria for defining
multipotent MSCs.21 These cells displayed typical cell
morphology, adherence to plastics, and efficient tri-lineage
differentiation capacity. Additional cell surface antigens
were also detected and quantified by flow cytometry. Our
immuno-phenotyping results were consistent with the
aforementioned studies22,23 in that the ADSCs between the
third passage to the fifth passage were strongly positive for
markers associated with MSCs and negative for those asso-
ciated with hematopoietic stem cells or endothelial cells.
Therefore, the cultured ADSCs prepared in our laboratory
for subsequent experiments represent a homogenous pop-
ulation of MSCs. These efforts were made to standardize
our cell preparations and allow for comparison between
scientific studies among laboratories.
Fibroblastic differentiation of stem cells has widespread
significance in the engineering of virtually all tissues
including fascia, tendons, ligaments, and as interstitial
filler of all organs. Lee et al induced bone marrow-derived
MSCs to become mature fibroblast-like cells and found
significant increases in the expression of collagen type I and
tenascin-C and a loss of multipotent differentiation ca-
pacity.24 We performed fibroblastic differentiation of
ADSCs with the aim of engineering fascia for pelvic floor
reconstruction to repair POP. In addition to the two ECM
markers evaluated by Lee et al, we also evaluated the
Figure 8 Comparison of the histological characteristics between (A) the normal back skin with loose connective tissue, (B) the
control group (scaffold without cell seeding) with a thin but dense band formation, (C) the adipose-derived stem cells (ADSCs)
transplantation with lamellar connective tissue formation, and (D) transplantation of fibroblastic-differentiated ADSCs with ad-
hesive fibrotic tissue formation. H&E staining, original magnification, 400 (AeD); internal scale marker Z 100 mm. DM Z deep
muscle; SM Z superficial muscle.
Tissue-engineered fascia from adipose-derived SCs 713mRNA of collagen type III, collagen type V, and elastin via
RT-PCR because these molecules are considered important
in the vaginal wall and its supportive tissue.27,28 During the
fibroblastic differentiation of ADSCs, we found that there
was a statistically significant (p < 0.05) increase in gene
expression of cellular collagen type I and elastin, and an
increase in collagen type I/III and collagen type I/IIIþV
ratios concomitantly with cell morphological changes.
These changes may imply that ADSCs after fibroblastic
differentiation turned into functional fibroblast-like cells
with positively upregulated ECM metabolism in these cells.
The engraftment of tissue-engineered fascia equivalents
using ADSCs or fibroblastic-differentiated ADSCs resulted in
very different histological outcomes, which imply a po-
tential but different indication of these cells in fascia tissue
engineering. Recent studies regarding the vaginal wall and
its supportive tissue have demonstrated that the organi-
zation of various ECM molecules vary within the different
tissues to support normal pelvic function.27,28,29 Hirata
et al29 conducted a comparative histological study of
vaginal supportive tissues according to Delancey’s three
levels of vaginal support and found that the constitution of
collagen, elastin, and smooth muscle fibers varied
remarkably at different levels. Based on the histological
findings of current studies, we suggest that ADSC trans-
plantation, which results in well-organized lamellar con-
nective tissue formation, might have a potential role inrepairing the damaged vaginal fascia in POP patients.
Meanwhile, transplantation of fibroblastic-differentiated
ADSCs might be developed to suspend (level I) and attach
(level II) the vaginal fascia peripherally to the pelvic side
walls since dense adhesive fibrous tissue has been formed
from transplantation. Furthermore, the implantation of a
scaffold without cell seeding (the control group), which
resulted in fibrotic tissue deposition and tissue contracture,
demonstrated similar findings to current preclinical and
clinical studies of surgical grafts implantation.14,30,31
The present study has the following limitations: the
difficulty of directly translating the knowledge gained from
the animal model to humans and the short-term (12 weeks)
histological outcomes need to be verified by further long-
term studies. Besides, a critical point in this study that
needs further clarification is whether the neo-tissue formed
directly from transplanted human cells or indirectly by
paracrine stimulation of murine resident cells. It has been
reported that the therapeutic effects of MSCs might be
attributed to several mechanisms including cell differenti-
ation, fusion, paracrine effects and regulation of microen-
vironment, etc.32 Although human ADSCs were labeled with
a dye (Vybrant DiI; Molecular Probes) before trans-
plantation in this study, the possibility of contamination
could not be ruled out. Future work aimed at the distinc-
tion of the source of cells and ECM in the neo-tissue for-
mation by advanced cellular and molecular methodologies
714 M.-J. Hung et al.may offer insights into the mechanisms through which
ADSCs can contribute to fascia repair and regeneration.
In conclusion, our results suggest that an ADSC-seeded
implant is better than implant alone in enhancing tissue
regeneration after transplantation. ADSCs with or without
fibroblastic differentiation might have a potential role in
fascia tissue engineering to repair POP in the future. Before
this approach can be applied for clinical use, new studies
are needed to establish the formation, fate, and function of
the tissue-engineered fascia equivalents from ADSCs.Acknowledgments
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